Effect of whole-body hyperthermia on lonidamine and doxorubicin pharmacokinetics and toxicity in dogs

References

• Bates D. A., Mac Killop W. J. Hyperthermia, adriamycin transport, and cytotoxicity in drug-sensitive and -resistant Chinese hamster ovary cells. Cancer Research 1986; 46: 5447–5481
   Google Scholar
• Benet L. Z., Massoud N. Pharmacokinetics. Pharmacokinetic Basis for Drug Treatment, L. Z. Benet, N. Massoud, J. G. Gambertoglio. Raven, New York 1984; 1–28
   Google Scholar
• Brenner D. E., Van Echo D., Riggs C. E., Wesley M., Whitacre M., Aisner J., Wiernik P. H., Bachur N. R. Hyperthermia induced changes in adriamycin pharmacokinetics in sarcoma patients receiving whole-body hyperthermia (WBH), adriamycin (ADR) and cyclophosphamide (CTX). Proceedings of AACR and ASCO 1981; 22: 260
   Google Scholar
• Bunch S. E., Polak D. M., Hornbuckle W. E. A modified laparoscopic approach for liver biopsy in dogs. Journal of the American Veterinary Medical Association 1985; 10: 1032–1035
   Google Scholar
• Center S. A., Leveille C. R., Baldwin B. H., Tennant B. C. Direct spectrometric determination of serum bile acids in the dog and cat. American Journal of Veterinary Research 1984; 45: 2043–2050
   PubMed Web of Science ®Google Scholar
• Chitnis M., Adwankar M. Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia. Tumori 1986; 72: 469–473
   PubMedGoogle Scholar
• Chitnis M., Juvekar A., Adwankar M., Advani S. Inhibition of DNA synthesis by lonidamine and hyperthermia in human chronic myeloid leukemia cells. Anticancer Research 1986; 6: 749–752
   PubMedGoogle Scholar
• Cox S. K., Wilke A. V., Frazier D. L. Determination of adriamycin in plasma and tissue biopsies. Journal of Chromatography, Biomedical Applications 1991; 564: 322–329
   PubMedGoogle Scholar
• Daly J. M., Wang Y. M., Kapelanski D., Frazier O. H. Systemic thermochemotherapy: toxicity and plasma pharmacokinetics of methotrexate and doxorubicin. Journal of Surgical Research 1984; 37: 343–347
   PubMedGoogle Scholar
• De Fabritiis P., Sandrelli A., Covelli A., Simone F., De Felice L., Pulsoni A., Zupi G., Mandelli F. In vitro pharmacological purging of human bone marrow is enhanced by lonidamine. Experimental and Molecular Pathology 1989; 50: 210–219
   PubMed Web of Science ®Google Scholar
• De Martino D., Malorni W., Bellocci M., Floridi A., Marcante M. L. Effects of AF 1312TS and lonidamine on mammalian testis. A morphologic study. Chemotherapy 1981; 27(Supl. 1): 27–42
   Google Scholar
• Floridi A., Gambacurta A., Bagnato A., Bianchi C., Paggi M. G., Silvestrini B., Caputo A. Modulation of adriamycin uptake by lonidamine in Ehrlich ascites tumor cells. Experimental and Molecular Pathology 1988; 49: 421–431
   PubMedGoogle Scholar
• Gibaldi M. Compartmental and noncompartmental pharmacokinetics. Biopharmaceutics and Clinical Pharmacokinetics, 4th edn. Lea & Febiger, Philadelphia 1991; 14–23
   Google Scholar
• Greco C., Cavaliere R., Giovanella B., Natali P. G., Zupi G. Effect of sequential application of hyperthermia and chemotherapy on the survival of a thermoresistant human melanoma cell line. Cancer Biochemistry-Biophysics 1987; 9: 223–232
   PubMedGoogle Scholar
• Hahn G. M., Braun J., Har-Kedar I. Thermochemotherapy: synergism between hyperthermia (42–43°) and adriamycin (or bleomycin) in mammalian cell inactivation. Proceedings of the National Academy of Sciences, USA 1975; 72: 937–940
   PubMed Web of Science ®Google Scholar
• Honess D. J., Bleehen N. M. Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCMU: a lack of therapeutic gain. British Journal of Cancer 1982; 46: 236–248
   PubMedGoogle Scholar
• Kim J. H., Kim S. H., Alfieri A., Young C. S., Silvestrini B. Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo. Oncology 1984; 41((Suppl. 1))30–35
   PubMedGoogle Scholar
• Leibovici J., Klorin G., Huszar M., Hoenig S., Klein O., Michowitz M., Pinchassov A. Sensitivity of thermochemotherapy of AKR lymphoma and B16 melanoma variants of malignancy. Clinical and Experimental Metastasis 1990; 8: 33–46
   PubMed Web of Science ®Google Scholar
• Lombard C. W. Normal values of the canine M-mode echocardiogram. American Journal of Veterinary Research 1984; 45: 2015–2018
   PubMed Web of Science ®Google Scholar
• Mimnaugh E. G., Waring R. W., Sikic B. I., Magin R. L., Drew R., Litterst C. L., Gram T. E., Guarino A. M. Effect of whole body hyperthermia on the disposition and metabolism of adriamycin in rabbits. Cancer Research 1978; 38: 1420–1425
   PubMed Web of Science ®Google Scholar
• Myers C. E., Chabner B. A. Anthracyclines. Cancer Chemotherapy: Principles and Practice, B. A. Chabner, J. M. Collins. J. B. Lippincott, Philadelphia 1990; 356–381
   Google Scholar
• Nagaoka S., Kawasaki S., Sasaki K., Nakanishi T. Intracellular uptake, retention and cytotoxic effect of adriamycin combined with hyperthermi. in vitro. Japanese Journal of Cancer Research (Gann) 1986; 77: 205–211
   PubMedGoogle Scholar
• Newman R. A., Dogramatzis D., Benvenuto J. A., Trevino M., Stephens L. C., Wondergem J., Strebel R., Baba H., Bull J. M. Effect of whole-body hyperthermia on pharmacokinetics and tissue distribution of doxorubicin. International Journal of Hyperthermia 1992; 8: 79–85
   PubMed Web of Science ®Google Scholar
• Ning S., Hahn G. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cell. in vitro. Cancer Research 1990; 50: 7867–7870
   PubMed Web of Science ®Google Scholar
• Osborne E. J., Mackillop W. J. The effect of exposure to elevated temperatures on membrane permeability to adriamycin in Chinese hamster ovary cell. in vitro. Cancer Letters 1987; 37: 213–224
   PubMed Web of Science ®Google Scholar
• Page R. L., Thrall D. E., Dewhirst M. W., Macy D. W., George S. L., McEntee M. C., Heidner G. L., Novotney C. A., Allen S. A., Withrow S. J., Ogilvie G. K., Gillette E. L. Phase I study of melphalan and whole-body hyperthermia in dogs with malignant melanoma. International Journal of Hyperthermia 1991; 7: 559–566
   PubMed Web of Science ®Google Scholar
• Page R. L., Macy D. W., Ogilvie G. K., Rosner G. L., Dewhirst M. W., Thrall D. E., Withrow S. J., McEntee M. C., Cline J. M., Heidner G. L., Novotney C. S., Gillette E. L. Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. International Journal of Hyperthermia 1992; 8: 187–197
   PubMed Web of Science ®Google Scholar
• Price G. S., Page R. L., Riviere J. E., Cline J. M., Thrall D. E. Pharmacokinetics and toxicity of oral and intravenous lonidamine in dogs. Cancer Chemotherapy and Pharmacology 1995a, in press
   Google Scholar
• Price G. S., Page R. L., Riviere J. E., Cline J. M., Thrall D. E. Effect of whole body hyperthermia on the pharmacokinetics and toxicity of lonidamine in dogs. International Journal of Hyperthermia 1995b; 11: 531–544
   PubMed Web of Science ®Google Scholar
• Rice G. C., Hahn G. M. Modulation of adriamycin transport by hyperthermia as measured by fluorescence-activated cell sorting. Cancer Chemotherapy and Pharmacology 1987; 20: 183–187
   PubMedGoogle Scholar
• Riviere J. E., Page R. L., Dewhirst M. W., Tyczkowska K., Thrall D. E. Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs. International Journal of Hyperthermia 1986; 2: 351–358
   PubMedGoogle Scholar
• Riviere J. E., Page R. L., Rogers R. A., Chang S. K., Dewhirst M. W., Thrall D. E. Nonuniform alteration of cis-diamminedichloroplatinum(II) tissue distribution in dogs with whole body hyperthermia. Cancer Research 1990; 50: 2075–2080
   PubMed Web of Science ®Google Scholar
• Robins H. I., Neville A. J. Biology and methodology of whole-body hyperthermia. Hyperthermia in Cancer Treatment, L. J. Anghileri, J. Robert. CRC Press, Boca Raton 1986; vol 3: 183–206
   Google Scholar
• Robins H. I., Longo W. L., Lagoni R. K., Neville A. J., Hugander A., Schmitt C. L., Riggs C. Phase I trial of lonidamine with whole body hyperthermia in advanced cancer. Cancer Research 1988; 48: 6587–6592
   PubMed Web of Science ®Google Scholar
• Rosenthal R. C. Chemotherapy. Clinical Veterinary Oncology, S. J. Withrow, E. G. MacEwen. McGraw-Hill, Philadelphia 1989; 63–78
   Google Scholar
• Silvestrini B., Hahn G. M., Cioli V., De Martino C. Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumor systems. British Journal of Cancer 1983; 47: 221–231
   PubMedGoogle Scholar
• Steel R. G. D., Torrie J. H. Analysis of variance I. The one-way classification. Principles and Procedures of Statistics: A Biometrical Approach, 2nd edn. McGraw-Hill, New York 1980a; 137–171
   Google Scholar
• Steel R. G. D., Torrie J. H. Comparisons involving two sample means. Principles and Procedures of Statistics: a Biometrical Approach, 2nd edn. McGraw-Hill, New York 1980b; 86–121
   Google Scholar
• Steel R. G. D., Torrie J. H. Linear regression. Principles and Procedures of Statistics: A Biometrical Approach, 2nd edn. McGraw-Hill, New York 1980c; 239–271
   Google Scholar
• Szekely J. G., Lobreau A. U., Delaney S., Raaphorst G. P., Feeley M. Morphological effects of lonidamine on two human-tumor cell culture lines. Scanning Electron Microscopy 1989; 3: 681–693
   Google Scholar
• Thrall D. E., Page R. L., Dewhirst M. W., Meyer R. E., Hoopes P. J., Kornegay J. N. Temperature measurements in normal and tumor tissue of dogs undergoing whole body hyperthermia. Cancer Research 1986; 46: 6229–6235
   PubMed Web of Science ®Google Scholar
• Wilke A. V., Jenkins C., Milligan A. J., Legendre A., Frazier D. L. Effect of hyperthermia on normal tissue toxicity and on adriamycin pharmacokinetics in dogs. Cancer Research 1991; 51: 1680–1683
   PubMed Web of Science ®Google Scholar
• Wondergem J., Bulger R. E., Strebel F. R., Newman R. A., Travis E. L., Stephens L. C., Bull J. M. C. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Research 1988; 48: 440–446
   PubMed Web of Science ®Google Scholar
• Wondergem J., Stephens L. C., Strebel F. R., Baba H., Ohno S., Siddik Z. H., Newman R. A., Bull J. C. Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues. Cancer Research 1991; 51: 3559–3567
   PubMed Web of Science ®Google Scholar
• Zupi G., Greco C., Laudonio N., Benassi M., Silvestrini B., Caputo A. In vitro and in vivo potentiation of lonidamine of the antitumor effect of adriamycin. Anticancer Research 1986; 6: 1245–1250
   PubMed Web of Science ®Google Scholar